IMRA
IMARA Inc. [IMRA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IMRA Stock Summary
In the News
IMRA Financial details
Company Rating
Buy
Market Cap
165.8M
Income
-5.22M
Revenue
0
Book val./share
0.01
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
41
Optionable
No
Shortable
Yes
Earnings
04 May 2023
P/E
7087.8
Forward P/E
-
PEG
-467.44
P/S
-
P/B
401.53
P/C
632
P/FCF
-4.2
Quick Ratio
26.7
Current Ratio
27.23
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
4.88
EPS next Y
-
EPS next Q
-
EPS this Y
-102.54%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
25%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
5%
ROE
13%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.9739-6.32
52W High
-
52W Low
-
RSI
-
Rel Volume
2.34
Avg Volume
116.26K
Volume
271.72K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
15.96%
-
-
-
-
Beta
1.08129
-
-
Volatility
0.38%, 0.38%
Prev Close
0%
Price
6.32
Change
21.31%
IMRA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -1.2 | -9.69 | -11.74 | -9.45 | 0.24 | |
| Operating cash flow per share | -0.93 | -9.27 | -10.74 | -8.64 | -5.41 | |
| Free cash flow per share | -0.93 | -9.33 | -10.75 | -8.64 | -5.47 | |
| Cash per share | 0.78 | 12.24 | 25.34 | 16.67 | 13.42 | |
| Book value per share | -2.79 | 12.25 | 24.25 | 15.89 | 13.71 | |
| Tangible book value per share | -2.79 | 12.25 | 24.25 | 15.89 | 13.71 | |
| Share holders equity per share | -2.79 | 12.25 | 24.25 | 15.89 | 13.71 | |
| Interest debt per share | 0 | 0 | 0 | 0.12 | -10.79 | |
| Market cap | 141.66M | 35.41M | 76.76M | 12.18M | 26.88M | |
| Enterprise value | 134.28M | 30.48M | 29.06M | -35.47M | -61.32M | |
| P/E ratio | -12.5 | -1.55 | -1.88 | -0.24 | 17.06 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -16.14 | -1.62 | -2.05 | -0.26 | -0.76 | |
| PFCF ratio | -16.14 | -1.61 | -2.05 | -0.26 | -0.75 | |
| P/B Ratio | -5.38 | 1.22 | 0.91 | 0.14 | 0.3 | |
| PTB ratio | -5.38 | 1.22 | 0.91 | 0.14 | 0.3 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -11.84 | -1.27 | -0.7 | 0.69 | 0.89 | |
| EV to operating cash flow | -15.3 | -1.39 | -0.78 | 0.76 | 1.72 | |
| EV to free cash flow | -15.3 | -1.38 | -0.78 | 0.76 | 1.71 | |
| Earnings yield | -0.08 | -0.65 | -0.53 | -4.2 | 0.06 | |
| Free cash flow yield | -0.06 | -0.62 | -0.49 | -3.84 | -1.34 | |
| Debt to equity | 0 | 0 | 0 | 0.01 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0.01 | 0 | |
| Net debt to EBITDA | 0.65 | 0.2 | 1.15 | 0.93 | 1.28 | |
| Current ratio | 4.21 | 7.29 | 14.47 | 12.86 | 48.98 | |
| Interest coverage | 0 | 0 | 0 | 0 | -0.01 | |
| Income quality | 0.77 | 0.93 | 0.9 | 0.91 | -23.9 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0.01 | 0 | 0 | 0.01 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | -4.24 | -0.19 | -0.12 | -0.59 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 8.68 | 51.68 | 80.05 | 58.11 | 8.6 | |
| ROIC | 0.41 | -0.81 | -0.49 | -0.59 | 0.01 | |
| Return on tangible assets | -1.47 | -0.69 | -0.45 | -0.55 | 0.02 | |
| Graham Net | -2.82 | 10.39 | 23.5 | 15.26 | 13.14 | |
| Working capital | 5.87M | 26.43M | 84.16M | 85.49M | 87.81M | |
| Tangible asset value | -26.32M | 28.92M | 84.44M | 86.03M | 90.13M | |
| Net current asset value | -26.32M | 26.24M | 84M | 85.08M | 87.81M | |
| Invested capital | 0 | 0 | 0 | 0.01 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 1.28M | 1.81M | 2.17M | 1.25M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.43 | -0.79 | -0.48 | -0.59 | 0.02 | |
| Capex per share | 0 | -0.06 | -0.01 | 0 | -0.06 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.67 | 4.89 | 0 | 0 | 0 | |
| Operating cash flow per share | -0.64 | -0.29 | 0 | 0 | 0 | |
| Free cash flow per share | -0.64 | -0.29 | 0 | 0 | 0 | |
| Cash per share | 8.57 | 13.37 | 0.02 | 0.01 | 0.01 | |
| Book value per share | 8.72 | 13.66 | 0.02 | 0.01 | 0.01 | |
| Tangible book value per share | 8.72 | 13.66 | 0.02 | 0.01 | 0.01 | |
| Share holders equity per share | 8.72 | 13.66 | 0.02 | 0.01 | 0.01 | |
| Interest debt per share | 0.04 | -0.07 | 0 | 0 | 0 | |
| Market cap | 14.98M | 26.98M | 117.01B | 258.87B | 259.32B | |
| Enterprise value | -34.51M | -61.22M | 116.72B | 258.75B | 259.24B | |
| P/E ratio | -0.85 | 0.21 | 0 | -3.87K | -3.12K | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -3.57 | -14.35 | -5.61K | 61.71K | 0 | |
| PFCF ratio | -3.55 | -14.35 | -5.61K | 61.71K | 0 | |
| P/B Ratio | 0.26 | 0.3 | 401.53 | 927.88 | 990.71 | |
| PTB ratio | 0.26 | 0.3 | 401.53 | 927.88 | 990.71 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 7.3 | 18.8 | -7.11K | -12.85K | -10.69K | |
| EV to operating cash flow | 8.21 | 32.56 | -5.6K | 61.68K | 0 | |
| EV to free cash flow | 8.17 | 32.56 | -5.59K | 61.68K | 0 | |
| Earnings yield | -0.29 | 1.2 | 0 | 0 | 0 | |
| Free cash flow yield | -0.28 | -0.07 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 10.47 | 27.08 | 17.79 | 6.24 | 3.05 | |
| Current ratio | 32.51 | 48.98 | 27.23 | 30.96 | 22.24 | |
| Interest coverage | -19.96 | -73.82 | 0 | 0 | 0 | |
| Income quality | 0.91 | -0.06 | 1.42 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.2 | 0 | -0.46 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 11.44 | 38.78 | 0 | 0.01 | 0.01 | |
| ROIC | -0.08 | 0.35 | 0 | -0.07 | -0.09 | |
| Return on tangible assets | -0.07 | 0.35 | 0 | -0.06 | -0.08 | |
| Graham Net | 8.29 | 13.09 | 0.02 | 0.01 | 0.01 | |
| Working capital | 57.29M | 87.81M | 287.06M | 274.03M | 256.53M | |
| Tangible asset value | 57.29M | 90.13M | 291.42M | 278.99M | 261.75M | |
| Net current asset value | 57.29M | 87.81M | 286.55M | 273.67M | 256.31M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 951K | 458K | 3M | 4.35M | 2.17M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.08 | 0.36 | 0 | -0.06 | -0.08 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
IMRA Frequently Asked Questions
What is IMARA Inc. stock symbol ?
IMARA Inc. is a US stock , located in Boston of Ma and trading under the symbol IMRA
What is IMARA Inc. stock quote today ?
IMARA Inc. stock price is $6.32 today.
Is IMARA Inc. stock public?
Yes, IMARA Inc. is a publicly traded company.
Company Profile
- Volume Average 116.26K
- Market Capitalization 165.8M
- Employee 41
- CEO Dr. Rahul D. Ballal Ph.D.
- Headquarters Boston,MA,US
- IPO Date 2020-03-12
-
Website
https://imaratx.com 
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
